The objective of the study was to evaluate if intraperitoneal Ab-T1 treatment (once/week) inhibits pTau spreading in AD/tauopathy hTau.K257T/P301S mice seeded with pathological Tau from human brains of patients with Alzheimer’s disease (AD-Tau). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.